Account

Abstract not indexed. Read at publisher

Topics

Infertility > Medical Management > Tamoxifen TherapyInfertility > Luteal Phase Defect > Pharmacological TreatmentReproductive Endocrinology > Ovulation Induction > Anti-Estrogen Agents
tamoxifen treatment luteal phase deficiency infertility, inadequate luteal phase tamoxifen ovulation induction, selective estrogen receptor modulator luteal phase defect, tamoxifen infertility treatment hormonal therapy, luteal phase insufficiency anti-estrogen treatment, tamoxifen versus clomiphene luteal phase support, ovulation induction tamoxifen luteal phase inadequacy, tamoxifen progesterone luteal support infertile women, Tajima tamoxifen luteal phase infertility, anti-estrogen therapy female infertility ovulatory dysfunction
PMID 6421628 6421628 DOI 10.1016/s0015-0282(16)47730-7 10.1016/s0015-0282(16)47730-7

Cite this article

Tajima, C. (1984). Tamoxifen in the treatment of infertile patients associated with inadequate luteal phase. *Fertility and Sterility*, *41*(3), 470-472. https://doi.org/10.1016/s0015-0282(16)47730-7

Keywords

Adult, Corpus Luteum/physiopathology, Female, Follicle Stimulating Hormone/blood, Humans, Hypothalamo-Hypophyseal System/drug Effects, Infertility, Female/drug Therapy, Luteal Phase/drug Effects, Luteinizing Hormone/blood, Menstruation/drug Effects, Progesterone/blood, Tamoxifen/therapeutic Use, Tamoxifen, Progesterone, Luteinizing Hormone, Follicle Stimulating Hormone

Related articles

Recurrent pregnancy loss: a committee opinion
Practice Committee of the American Society for Reproductive Medicine 2026 Fertility and Sterility

Current strategies for the assessment and treatment of recurrent pregnancy loss are discussed. This replaces the previous document, titled, "Evaluation and treatment of recurrent pregnancy loss: a com...